Beam Therapeutics BEAM
NASDAQ BEAM
$24.39 -0.06 (-0.25%)
At close: Oct 1, 2026 · 4:00 PM EDT

Beam Therapeutics (BEAM) Return on Equity [ROE] (2020 - 2026)

Updated

Beam Therapeutics' Return on Equity [ROE] was -7.60% in Q2 2026, up 28.93 percentage points from -36.53% a year earlier but down 1.94 percentage points from the prior quarter.

Analysis

Beam Therapeutics (BEAM) Return on Equity [ROE] (2020 - 2026) Analysis & Trends

For FY2025, Return on Equity [ROE] at Beam Therapeutics came in at -8.11%, up 35.82 percentage points from FY2024.

  • Return on Equity [ROE] shows a five-year change of +867.30 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Equity [ROE] was -43.94% in FY2024 (-28.48 pp), -15.46% in FY2023 (+18.33 pp), -33.79% in FY2022 (+35.34 pp) and -69.13% in FY2021 (+806.29 pp).
  • Quarterly Return on Equity [ROE] has moved between -48.58% (Q4 2024) and -5.67% (Q1 2026) over five years.
  • Compared with a year earlier, Return on Equity [ROE] has increased for three straight quarters, with an average year-over-year change of +2.51 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Equity [ROE] over five years was Q1 2022 (a gain of 63.65 percentage points); the worst was Q4 2024 (a drop of 34.37 percentage points).
  • Per Business Quant data, BEAM's Return on Equity [ROE] in the three quarters before Q2 2026 was -5.67% (Q1 2026), -7.27% (Q4 2025) and -41.08% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.32%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 7.21%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 84.40%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 21.39%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 83.75%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -18.38%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.97%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 22.24%
10 Beam Therapeutics 2.52 Bn 2.52 Bn - -7.60%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -7.60%
Mar 31, 2026 -5.67%
Dec 31, 2025 -7.27%
Sep 30, 2025 -41.08%
Jun 30, 2025 -36.53%
Mar 31, 2025 -41.60%
Dec 31, 2024 -48.58%
Sep 30, 2024 -16.68%
Jun 30, 2024 -15.46%
Mar 31, 2024 -13.55%
Dec 31, 2023 -14.21%
Sep 30, 2023 -38.50%
Jun 30, 2023 -37.40%
Mar 31, 2023 -38.97%
Dec 31, 2022 -38.39%
Sep 30, 2022 -40.18%
Jun 30, 2022 -30.48%
Mar 31, 2022 -27.47%
Dec 31, 2021 -41.92%
Sep 30, 2021 -46.82%
API Access

Beam Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=BEAM&period=max&api_key=YOUR_API_KEY